ACTB and hepatocellular carcinoma: Particularly convincing evidence of how candidate HKGs can vary in a changing clinical context was provided by the study by Waxman and Wurmbach, who analyzed the differential expression of six genes, including GAPDH and ACTB, over eight consecutive stages of hepatitis C virus-induced hepatocellular carcinoma.